|

Vaccine + PolyICLC Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Olivera Finn1

Indications

  • Non-small Cell Lung Cancer (NSCLC)1
  • Lung Cancer1
  • Cancer1

Pittsburgh, Pennsylvania1 trial

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

UPMC Hillman Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.